Document is current
Any future updates will be listed below
-
Authors
Simpson, Kathryn L.
Rothwell, Dominic G.
Blackhall, Fiona
Dive, Caroline https://orcid.org/0000-0002-1726-8850
- License Information
-
More Information
Article History
Accepted: 19 February 2025
First Online: 10 April 2025
Competing interests
: K.S. and D.R. declare no competing interests. F.B. declares the following: advisory board honoraria, speaker fees and research funding from Amgen. C.D. declares the following: research funding/educational research grants from AstraZeneca, Astex Pharmaceuticals, Biomodal, Bioven, Amgen, Carrick Therapeutics, Merck, Taiho Oncology, GSK, Bayer, Boehringer Ingelheim, Roche, Bristol Myers Squibb, Novartis, Celgene, Epigene Therapeutics, Angle, Menarini, Clearbridge Biomedics, Thermo Fisher Scientific and Neomed Therapeutics; and honoraria for consultancy and/or advisory boards from Biocartis, Merck, AstraZeneca, GRAIL, Boehringer Ingelheim and Vall d’Hebron Institute of Oncology.
